Takeuchi Ario 武内在雄

… Alternative Names

TAKEUCHI ARIO 武内在雄

Less

Researcher Number	30586756
Affiliation (based on the past Project Information) *help	2021: 九州大学, 大学病院, 講師 2018 – 2019: 九州大学, 大学病院, 助教 2017: 九州大学, 医学(系)研究科(研究院), 助教 2014 – 2015: 九州大学, 大学病院, 助教 2013: 九州大学, 医学(系)研究科(研究院), 助教
Review Section/Research Field	Principal Investigator Urology / Basic Section 56030:Urology-related Except Principal Investigator Urology
Keywords	Principal Investigator BCG / 膀胱癌 / 膀胱がん / ＢＣＧ / インターロイキン15 / PD-1経路阻害薬 / 免疫チェックポイント阻害薬 / 免疫チェックポイント阻害剤 / BCG治療 / 新戦略 Except Principal Investigator 癌 / シグナル伝達 / 発現制御

A new therapeutic strategy for metastatic bladder cancer using BCG intravesical infusionPrincipal Investigator
- Principal Investigator
  
  武内在雄
- Project Period (FY)
  2021 – 2023
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56030:Urology-related
- Research Institution
  Kyushu University
The development of new BCG Immunotherapy against bladder cancer with immune checkpoint inhibitorPrincipal Investigator
- Principal Investigator
  
  Takeuchi Ario
- Project Period (FY)
  2017 – 2019
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Urology
- Research Institution
  Kyushu University
The challenge to develop a new BCG immunotherapy against non-muscle invasive bladder cancerPrincipal Investigator
- Principal Investigator
  
  TAKEUCHI ARIO
- Project Period (FY)
  2014 – 2015
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Urology
- Research Institution
  Kyushu University
腎・尿路性器癌の進展におけるストレス応答機構を標的とした治療法の開発
- Principal Investigator
  
  内藤誠二
- Project Period (FY)
  2013 – 2014
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Urology
- Research Institution
  Kyushu University

All 2018 2016 2014 2013

All Journal Article Presentation

[Journal Article] Inhibition of RSK/YB-1 signaling enhances the anti-cancer effect of enzalutamide in prostate cancer.2014
- Author(s)
  Shiota, M., Yokomizo, A., Takeuchi, A., Itsumi, M., Imada, K., Kashiwagi, E., Inokuchi, J., Tatsugami, K., Uchiumi, T., Naito, S.
- Journal Title
  
  The Prostate
  
  Volume: 74 Pages: 959-969
- DOI
  10.1002/pros.22813
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PROJECT-25253041, KAKENHI-PROJECT-25462483
[Journal Article] Targeting ribosomal S6 kinases/Y-box binding protein-1 signaling improves cellular sensitivity to taxane in prostate cancer.2014
- Author(s)
  Shiota, M., Itsumi, M., Yokomizo, A., Takeuchi, A., Imada, K., Kashiwagi, E., Inokuchi, J., Tatsugami, K., Uchiumi, T., Naito, S.
- Journal Title
  
  The Prostate
  
  Volume: 74 Pages: 829-838
- DOI
  10.1002/pros.22799
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PROJECT-25253041, KAKENHI-PROJECT-25462483
[Presentation] Rationale and possibility of intravesical Bacillus Calmette-Guerin therapy with cytokine against bladder cancer2018
- Author(s)
  Ario Takeuchi
- Organizer
  EAU2018
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K11147
[Presentation] ＢＣＧ、インターロイキン１５併用療法についての検討2016
- Author(s)
  武内在雄ら
- Organizer
  日本泌尿器科学会総会
- Place of Presentation
  宮城（仙台）
- Year and Date
  2016-04-21
- Data Source
  KAKENHI-PROJECT-26861274
[Presentation] Efficacy of Recombinant Bacille Calmette-Guerin Secreting Interleukin-15 against bladder cancer.2016
- Author(s)
  Ario Takeuchi et al
- Organizer
  31st Annual Congress of the European Association of Urology
- Place of Presentation
  Munich
- Year and Date
  2016-03-11
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-26861274
[Presentation] Interaction between docetaxel resistance and castration resistance in prostate cancer: Implications of Twist1, YB-1 and androgen receptor2014
- Author(s)
  Shiota M, Kashiwagi E, Yokomizo A, Takeuchi A, Dejima T, Itsumi M, Tatsugami K, Inokuchi J, Uchiumi T, Naito
- Organizer
  AUA 2014 Annual Meeting
- Place of Presentation
  Orlando, FL, USA
- Year and Date
  2014-05-18
- Data Source
  KAKENHI-PROJECT-25462483
[Presentation] Inhibition of RSK/YB-1 signaling enhances the anti-cancer effect of enzalutamide in prostate cancer2014
- Author(s)
  Shiota M, Yokomizo A, Takeuchi A, Itsumi M, Imada K, Kashiwagi E, Inokuchi J, Tatsugami K, Uchiumi T, Naito S
- Organizer
  第73回日本癌学会学術総会
- Place of Presentation
  横浜
- Year and Date
  2014-09-25
- Data Source
  KAKENHI-PROJECT-25462483
[Presentation] Y-box binding protein-1 promotes castration-resistant prostate cancer growth via androgen receptor expression2013
- Author(s)
  Shiota M, Takeuchi A, Song YH, Yokomizo A, Kashiwagi E, Uchiumi T, Kuroiwa K, Tatsugami K, Fujimoto N, Oda Y, Naito S
- Organizer
  AUA 2013 Annual Meeting
- Place of Presentation
  San Diego, USA
- Data Source
  KAKENHI-PROJECT-25462483

1. 内藤誠二 (40164107)

# of Collaborated Projects: 1 results

# of Collaborated Products: 5 results
2. 塩田真己 (20635445)

# of Collaborated Projects: 1 results

# of Collaborated Products: 5 results
3. 内海健

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results

Takeuchi Ario 武内 在雄

TAKEUCHI ARIO 武内 在雄

Research Projects

Research Products

Co-Researchers

A new therapeutic strategy for metastatic bladder cancer using BCG intravesical infusionPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

The development of new BCG Immunotherapy against bladder cancer with immune checkpoint inhibitorPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

The challenge to develop a new BCG immunotherapy against non-muscle invasive bladder cancerPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

腎・尿路性器癌の進展におけるストレス応答機構を標的とした治療法の開発

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Inhibition of RSK/YB-1 signaling enhances the anti-cancer effect of enzalutamide in prostate cancer.2014

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Targeting ribosomal S6 kinases/Y-box binding protein-1 signaling improves cellular sensitivity to taxane in prostate cancer.2014

Author(s)

Journal Title

DOI

Data Source

[Presentation] Rationale and possibility of intravesical Bacillus Calmette-Guerin therapy with cytokine against bladder cancer2018

Author(s)

Organizer

Data Source

[Presentation] ＢＣＧ、インターロイキン１５併用療法についての検討2016

Author(s)

Organizer

Place of Presentation

Year and Date

Data Source

[Presentation] Efficacy of Recombinant Bacille Calmette-Guerin Secreting Interleukin-15 against bladder cancer.2016

Author(s)

Organizer

Place of Presentation

Year and Date

Data Source

[Presentation] Interaction between docetaxel resistance and castration resistance in prostate cancer: Implications of Twist1, YB-1 and androgen receptor2014

Author(s)

Organizer

Place of Presentation

Year and Date

Data Source

[Presentation] Inhibition of RSK/YB-1 signaling enhances the anti-cancer effect of enzalutamide in prostate cancer2014

Author(s)

Organizer

Place of Presentation

Year and Date

Data Source

[Presentation] Y-box binding protein-1 promotes castration-resistant prostate cancer growth via androgen receptor expression2013

Author(s)

Organizer

Place of Presentation

Data Source

Takeuchi Ario 武内在雄

TAKEUCHI ARIO 武内在雄